Key Stats for Humana Stock
- Price change for Humana stock: 7%
- $HUM Share Price as of Jun. 4: $350
- 52-Week High: $352
- $HUM Stock Price Target: $290
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
What Happened?
Humana (HUM) stock surged about 6%, leading a broad rally in health insurance stocks.
The trigger was a wave of bullish analyst notes on the managed care sector, built around two ideas:
Medical costs are moderating, and AI could unlock meaningful efficiency gains.
Bank of America upgraded UnitedHealth to Buy and raised its price target to $450, while Truist raised its UnitedHealth target to $440, both citing favorable Q1 medical cost trends and a strong setup heading into Q2 earnings.
A separate Morgan Stanley note framed managed care companies as potential beneficiaries of both utilization trends and AI upside.
Morgan Stanley estimated that AI efficiencies could deliver an average of 45% EPS upside across the group.
See analysts’ growth forecasts and price targets for Humana stock (It’s free) >>>
What the Market Is Telling Us About Humana Stock
Health insurance stocks have been under pressure for months over fears that medical costs were climbing faster than premiums could cover.
The recent move says the market is starting to question that narrative.
- When people use less healthcare, insurers pay out fewer claims. That gap between premiums collected and claims paid widens, and profits follow.
- Humana stock has gained 32% this year and 46% over the past month, supported by Q1 results showing an insurance segment benefit ratio of 89% and medical and pharmacy cost trends coming in slightly better than expected.
- The AI case adds another layer. Humana is already cutting costs through centralizing teams, expanding outsourcing, and automating processes.
- The company also set up a dedicated transformation office about 17 months ago to track and accelerate these initiatives across the business.
The goal is clear: double Medicare Advantage margin in 2026 and reach a sustainable 3% margin by 2028.
It’s not all smooth sailing. Management has signaled that it will reduce member benefits going into 2027 to protect margins, since program funding still doesn’t fully keep pace with rising medical costs. The turnaround is real but ongoing.
Still, the direction of travel has shifted. For long-term investors, Humana stock could have meaningful upside if the margin recovery plays out as planned and AI efficiencies start showing up in the numbers.
Estimate a company’s fair value instantly (Free with TIKR) >>>
How Much Upside Does Humana Stock Have From Here?
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
